Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Interval Cytoreductive Surgery With or Without HIPEC for Ovarian Cancer (FOCUS / KOV-HIPEC-04) [Phase 3]
Phase 3 clinical trial update on interval cytoreductive surgery with or without HIPEC for ovarian cancer (FOCUS / KOV-HIPEC-04), currently r…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors
This clinical trial update reports that data collection is ongoing for patients with low-grade ovarian and peritoneal tumors, with recruitme…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy [EARLY_Phase 1]
This early-phase study is evaluating the effects of a probiotic intervention on the gut and vaginal microbiomes in patients with advanced or…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy [Phase 2]
This Phase II randomized, open-label trial evaluates whether NiraParib maintenance after 3 cycles of platinum-based chemotherapy is non-infe…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Iparomlimab and Tuvonralimab (QL1706) Combined With Standard Chemotherapy or Combined With Intraperitoneal Perfusion Chemotherapy and Olaparib as Neoadjuvant Therapy for Advanced Ovarian Cancer [Phase 2]
A Phase 2 neoadjuvant trial in advanced ovarian cancer evaluating iparomlimab and tuvonralimab (QL1706) with either standard chemotherapy or…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors [Phase 1]
Phase 1 study update for NRM-823 in locally advanced or metastatic refractory solid tumors, currently recruiting. The trial lists head and n…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer [Phase 2]
A Phase 2 immunotherapy platform trial in platinum-resistant high-grade serous ovarian cancer is currently recruiting under the Canadian Can…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Study to Evaluate Folate Receptor Alpha (FRα) Expression in Adult Participants With Ovarian, Fallopian Tube, and Primary Peritoneal Cancer in Italy
AbbVie-sponsored clinical study in Italy to evaluate folate receptor alpha expression in adults with ovarian, fallopian tube, or primary per…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
This Phase 2 trial is evaluating the combination of lenvatinib, pembrolizumab, and paclitaxel for recurrent endometrial, ovarian, fallopian …
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer [EARLY_Phase 1]
This is a Phase 1 trial evaluating hyperthermic intraperitoneal chemotherapy with cisplatin during or before surgery for Stage III/IV ovaria…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: SEQUENTIAL PROFILING OF TUMOR-DERIVED CIRCULATING CELL-FREE DNA (ctDNA) IN ADVANCED OVARIAN CANCER PATIENTS [NA]
This clinical trial update outlines sequential profiling of tumor-derived circulating cell-free DNA (ctDNA) in patients with advanced ovaria…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma [Phase 1]
Phase 1 trial update for SynKIR-110 in mesothelin-expressing ovarian cancer, cholangiocarcinoma, and mesothelioma, currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: The Efficacy and Safety of Paclitaxel Monotherapy Versus Paclitaxel-Carboplatin Combination as Neoadjuvant Chemotherapy in Advanced Ovarian Cancer With High PARK2 Expression [Phase 2]
This Phase 2 clinical trial compares paclitaxel monotherapy to paclitaxel plus carboplatin as neoadjuvant chemotherapy in patients with adva…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies
A recruiting clinical trial from University Hospital Tuebingen is studying immunotherapy-related CRP kinetics in metastatic gynecological ca…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 trial update of P-MUC1C-ALLO1, an allogeneic CAR-T cell therapy, being studied in advanced or metastatic solid tumors. The study is …
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors [Phase 1]
Phase 1 clinical trial evaluating autologous B7-H3 CAR T cells for recurrent platinum-resistant ovarian cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Responses to Genetic Risk Modifier Testing Among Women With BRCA1/2 Mutations
This clinical trial update describes a study evaluating responses to genetic risk modifier testing in women with BRCA1/2 mutations; the stud…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: PLX038 for Treatment of Metastatic Platinum-resistant Ovarian, Primary Peritoneal, and Fallopian Tube Cancer [Phase 2]
Phase 2 clinical trial evaluating PLX038 for metastatic platinum-resistant ovarian cancer, fallopian tube cancer, and primary peritoneal can…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery [Phase 2]
Bevacizumab is being studied in a Phase 2 trial for ovarian cancer patients undergoing second-look surgery. The trial is currently active bu…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: NeoAdjuvant ChemoTherapy With KELIM Guided Interval vs. Delayed Interval Debulking Surgery [NA]
A clinical trial evaluating neoadjuvant chemotherapy guided by KELIM compared with delayed interval debulking surgery in ovarian cancer; the…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Healthy Volunteers Study
A healthy volunteers clinical study sponsored by the Abramson Cancer Center at Penn Medicine is recruiting, with ovarian cancer and genetic …
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours [Phase 1]
Phase 1 study evaluating AVA6000 in solid tumors, assessing safety, pharmacokinetics, and early efficacy; recruitment is ongoing across seve…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing [NA]
This clinical trial update describes evaluating a digital application designed to scale oncologist-initiated genetic testing across multiple…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
This update describes the Moonshot Study's genetic analysis of blood and tissue samples from patients with advanced cancer; the study status…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: The Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer Patients
A clinical trial sponsored by Far Eastern Memorial Hospital examines the role of blood perfusion in cervical cancer, cervical intraepithelia…